C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 38/17 (2006.01) C07K 14/47 (2006.01) C07K 14/82 (2006.01) C12N 5/10 (2006.01) C12N 15/62 (2006.01) C12Q 1/48 (2006.01) C12Q 1/68 (2006.01) G01N 33/50 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2288335
Exon 3 of BRCA2 encodes a transcriptional activator domain ("TAD"), including a primary activating region ("PAR") and an auxiliary activating region ("AAR"), flanked by two inhibitory regions ("IR1" and "IR2") which are bound by molecules which inhibit activation of transcription by the TAD. Appropriate fragments of BRCA2 polypeptide are useful in activating transcription and in assays for substances able to modulate transcriptional activation by BRCA2.
L'exon 3 de BRCA2 code un domaine de l'activateur transcriptionnel ("TAD") et comprend une région d'activation primaire ("PAR") et une région d'activation auxiliaire ("AAR") flanquées de deux régions inhibitrices ("IR1" et "IR2") liées par des molécules qui inhibent l'activation de transcription par TAD. Des fragments appropriés du polypeptide de BRCA2 sont utilisés dans la transcription d'activation et dans les dosages de substances capables de moduler l'activation transcriptionnelle effectuée par BRCA2.
Hughes-Davis Luke Tobit
Kouzarides Anthony
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Cancer Research Campaign Technology Limited
LandOfFree
Brca2 transcriptional activator domain and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Brca2 transcriptional activator domain and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Brca2 transcriptional activator domain and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1862040